Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-When M&A is Made in Britain

Mon, 02nd Aug 2021 14:24

* U.S. equity index futures suggest modest opening gains

* Euro STOXX 600 index up ~0.5%

* Dollar, gold, crude, bitcoin all dip

* U.S. 10-Year Treasury yield ~1.21%

Aug 2 - Welcome to the home for real-time coverage of
markets brought to you by Reuters reporters. You can share your
thoughts with us at markets.research@thomsonreuters.com

WHEN M&A IS MADE IN BRITAIN (0914 EDT/1314 GMT)

The U.S. takeover of engineer Meggitt is just the
latest in a series of M&A moves targeting Britain recently.

Morrison, Ultra, Vectura and Sanne
are other examples but beyond the market moving
headlines hard data also backs the view that Britain has proved
a particularly fertile ground for M&A this year.

Cross-border M&A with a UK target has increased by 340% to
$132.5 billion year to date, the latest Refintiv data to
end-July show. That's about nine times the 39% growth seen in
Europe and well above growth in the Americas (+200%) and Asia
(+182%).

"Now after all the fear mongering post Brexit has been
proven wrong UK companies are certainly of interest," says a
London-based trader. "Many companies and also Private Equity too
are looking to diversify in regard to location and are often
underinvested in the UK".

And beyond the volumes, investors in UK Plc appear to like
it, whereas it is becoming harder for acquirers to get a bargain
even though British companies are not necessarily overvalued at
this stage.

Meggitt shares shot up more than 60% this morning and that
in turn has helped the domestically focused mid-cap and FTSE 250
index race to a new record high.

"I am quite impressed by the massive premium which is being
paid for Meggitt," says the trader.

And AJ Bell investment director Russ Mould notes: "Private
equity firms have a reputation for trying to get a bargain, but
their tactics have been fully exposed this year and it now seems
rare for the first offer to be the winning one."

For more reading: BREAKINGVIEWS-UK plc’s latest sale is far
from on the cheap

(Danilo Masoni)

*****

S&P 500: FROM BULLISH FODDER TO BEARISH DUST? (0900 EDT/1300
GMT)

Amid on-going Federal Reserve support, the economic
re-opening, S&P 500 Q2 2021 year-over-year earnings
growth running at nearly 90%, and now a $1 trillion
infrastructure bill unveiled by U.S. Senators raising hopes of
more fiscal stimulus, there certainly is plenty of fodder for
bulls to be excited about.

So far, the S&P 500 index's record closing high was
on Monday July 26. Since then the benchmark index has
essentially chopped sideways, ending Friday just around 0.6%
below that high.

With this, however, a contrarian measure of sentiment, based
on the CBOE equity put/call (P/C) ratio, is exhibiting a pattern
that has preceded periods of market instability:

With the SPX's all-time high close, the 5-day moving average
of the P/C ratio fell to 41.6%. This put it just slightly above
its relatively recent, multi-decade lows. This measure's
depressed readings can flag an excessively bullish, or
especially complacent market, vulnerable to a reversal.

Indeed, what may be a more robust bearish signal is when the
moving average puts in a higher-low, against a higher SPX high.
This pattern developed ahead of declines of varying degree over
the last two years or so, including the severe sell-offs in late
2018 and early 2020.

In the wake of its 37.6% December 7 trough, which was its
lowest reading since around the time of the Y2K tech-bubble
peak, the measure has put in higher lows at 37.8% on January 14,
38.4% on February 11, and 39.6% on June 14. It has since vaulted
to 54.2%, despite just a modest drop in the index.

Thus, this measure may be signaling cracks are forming in
what has been solidly bullish sentiment. If so, instability may
be just around the corner.

(Terence Gabriel)

*****

FOR MONDAY'S LIVE MARKETS' POSTS PRIOR TO 0900 EDT/1300 GMT
- CLICK HERE:

(Terence Gabriel is a Reuters market analyst. The views
expressed are his own)

More News
26 May 2021 11:32

LIVE MARKETS-U.S. stock valuations face headwinds

* European shares erase gains* Fed soothes inflation fears* U.S. equity futures edge upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thoms...

Read more
26 May 2021 11:15

TOP NEWS: Carlyle offers GBP958 million for asthma drug maker Vectura

TOP NEWS: Carlyle offers GBP958 million for asthma drug maker Vectura

Read more
26 May 2021 11:06

LIVE MARKETS-Equities: another choppy summer?

* European shares up 0.1%* Fed soothes inflation fears* U.S. equity futures upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters...

Read more
26 May 2021 10:04

LIVE MARKETS-Who is paying dividends

* European shares up 0.2%* Fed soothes inflation fears* U.S. equity futures edge upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonre...

Read more
26 May 2021 09:33

LIVE MARKETS-M&S: a tricky morning call

* European shares up 0.2%* Fed soothes inflation fears* U.S. equity futures edge upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonre...

Read more
26 May 2021 09:18

UPDATE 2- British midcaps rise on strong earnings, Vectura shines

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Vectura surges on agreeing to $1.4 bln takeover by Carlyle* Marks & Spencer rises on positive profit outlook* Croda rises on double upgrade...

Read more
26 May 2021 08:47

LONDON MARKET OPEN: Vectura and Mediclinic boost FTSE 250 amid M&A

LONDON MARKET OPEN: Vectura and Mediclinic boost FTSE 250 amid M&A

Read more
26 May 2021 08:44

LIVE MARKETS-STOXX below peak, banks dip, some M&A action

* European shares up 0.2%* Fed soothes inflation fears* U.S. equity futures edge upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonre...

Read more
26 May 2021 08:44

LIVE MARKETS-STOXX below peak, banks dip, some M&A action

* European shares up 0.2%* Fed soothes inflation fears* U.S. equity futures edge upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonre...

Read more
26 May 2021 07:57

LONDON MARKET PRE-OPEN: Vectura and Spire Healthcare accept offers

LONDON MARKET PRE-OPEN: Vectura and Spire Healthcare accept offers

Read more
26 May 2021 07:56

Vectura to be taken over by Carlyle in £958m deal

(Sharecast News) - Pharmaceutical company Vectura said on Wednesday that it has agreed to be taken over by US private equity firm The Carlyle Group in a £958m deal, sending the shares sharply higher.

Read more
26 May 2021 07:38

UPDATE 1-UK pharma group Vectura agrees $1.4 bln takeover by Carlyle

(Adds details)LONDON, May 26 (Reuters) - Vectura Group, a British pharmaceutical company focused on inhaled medicines, said on Wednesday it had agreed a 958 million pound ($1.36 billion) takeover by global investment firm The Carlyle Group.Shareho...

Read more
26 May 2021 07:12

Vectura agrees 958 mln stg takeover by The Carlyle Group

LONDON, May 26 (Reuters) - Vectura Group, a British pharmaceutical company focused on inhaled medicines, said on Wednesday it had agreed a 958 million pound ($1.36 billion) takeover by global investment firm The Carlyle Group. ($1 = 0.7067 pounds...

Read more
20 May 2021 16:07

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
21 Apr 2021 10:06

Hikma resumes asthma drug launch, Vectura pays special dividend

Hikma resumes asthma drug launch, Vectura pays special dividend

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.